A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study

scientific article published on 27 October 2010

A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.FERTNSTERT.2010.09.023
P698PubMed publication ID20979997

P50authorPaul DevroeyQ7150251
Herman TournayeQ37835161
P2093author name stringWillem Verpoest
Evangelos G Papanikolaou
Basil Tarlatzis
Human Fatemi
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)1174-1177
P577publication date2010-10-27
P1433published inFertility and SterilityQ15724525
P1476titleA novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study
P478volume95

Reverse relations

cites work (P2860)
Q38829575An update on the prevention of ovarian hyperstimulation syndrome
Q38266109British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome
Q41545744Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial
Q35471131Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study
Q94572540ESHRE guideline: ovarian stimulation for IVF/ICSI†
Q33770533GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis
Q26800033GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
Q28077044GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
Q38222516GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future
Q34975528Gonadotrophins: The future
Q24193015Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
Q33799681Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
Q24186532Luteal phase support for assisted reproduction cycles
Q40278645Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study
Q41645905Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience
Q34163177Morphological changes of gonadotropin-releasing hormone neurons in the rat preoptic area across puberty
Q35591046New algorithm for OHSS prevention
Q55279761Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management.
Q41155931Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome
Q34009789Pharmaceutical options for triggering of final oocyte maturation in ART
Q34458877The Luteal Phase after GnRHa Trigger-Understanding An Enigma
Q48653020The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation

Search more.